Merck & Co., Inc. (MRK): A Bull Case Theory
We came across a bullish thesis on Merck & Co., Inc. on Darius Dark Investing’s Substack. In this article, we will summarize the bulls’ thesis on MRK.
Merck Sharp & Dohme Corp. (MRK)
This company is not actively trading or the ticker does belong to another company in our database now. The symbol (MRK) is currently associated with the following stock: Merck & Co. Inc. (MRK)
Sector: Pharmaceutical Preparations
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $33.22 | 550 | $18,268.75 | 750 | 2006-01-18 | Filing | |
| $45.65 | 200 | $9,130.56 | 200 | 2002-09-24 | Filing |
News See All
Wells Fargo Upgrades Merck (MRK) to Overweight, Raises Price Target to $125
On November 24, Wells Fargo upgraded Merck & Co., Inc. (NYSE:MRK) to Overweight from Equal Weight, raising its price target to $125 from $90, according to a report by The Fly.
15 Best Boring Dividend Stocks to Buy
Investing in high-quality dividend growth stocks may not seem very exciting.
BofA Raises Merck (MRK) Price Target to $105, Keeps Buy Rating
On November 17, BofA analyst Tim Anderson raised the firm’s price target on Merck & Co., Inc. (NYSE:MRK) to $105 from $98 and maintained a Buy rating on the shares, as reported by The Fly.
15 Best Stocks to Buy for Medium Term
The market is attempting to recover from last week’s losses as investors regroup after a sharp sell-off that hit both tech and crypto.
10 Hottest SMID-Cap Stocks So Far In 2025
SMID-caps, or Small- and mid-cap stocks, are often overlooked segments of the market.
Do You Believe in Merck & Co.’s (MRK) Upside Potential?
Antipodes Partners recently published its “Antipodes Global Value Strategy” third-quarter 2025 investor letter, highlighting the key performance stocks, portfolio changes, and the market outlook.
Merck (MRK) Delivers Strong Q3 2025 Earnings as Oncology Sales Drive Revenue Growth
Merck & Co. Inc. (NYSE:MRK) ranks among the best long-term stocks to buy according to D. E. Shaw. On October 30, Merck & Co. Inc.
9 Best Long-Term Stocks to Buy According to D. E. Shaw
David E. Shaw, a Stanford University alumnus, is among of the hedge fund managers who have mastered the complexities of quant trading and routinely generating significant returns.
Morgan Stanley Raises Merck (MRK) Price Target to $100, Maintains Equal Weight Rating
On November 3, Morgan Stanley analyst Terence Flynn raised the price target for Merck & Co., Inc.
Hedge Fund Resource Center Billionaire Hedge Funds
